12 postdoctoral-position-in-material-science positions at Karolinska Institutet in Sweden
-
applicants. Entry requirements Scholarships for postdoctoral qualification can be established for foreign researchers who place their qualifications in Sweden. The purpose of scholarships for postdoctoral
-
materials. Treatment : Explore medical and training-based interventions in collaboration with The Swedish School of Sport and Health Sciences (GIH), The Swedish Defence Materiel Administration (FMV), and The
-
of Medical Biochemistry and biophysics (MBB). The successful applicant will join a multidisciplinary research team with a translational profile in biomaterials and tissue engineering, and should have expertise
-
(transcriptomics and proteomics), and advanced imaging techniques. Learn more about us at: https://molmet.ki.se/filograna Your Mission The primary objective of this postdoctoral position is to study the role
-
. Methodologically, in vitro and in vivo approaches using experimental models and patient material will be used. Our group works in an inspiring and interactive research environment at the Karolinska University, Solna
-
to convey genetic material from one cell to another. We have developed a range of genetic engineering strategies to modify EVs for the purpose of drug delivery. In this project, we will develop novel
-
, Stockholm, Sweden We are looking for highly motivated and talented postdoctoral candidates to take the lead on challenging research projects in the lab of Professor Sten Eirik W. Jacobsen. The positions and
-
Do you want to contribute to improving health within the military community? We are looking for a researcher for a position as postdoc at the Unit for experimental traumatology (XT), which conducts
-
experimental work in a research laboratory environment. Flow cytometry and various cell and molecular biology methods and techniques are used to analyze patient material in our studies. Processing patient
-
Zhichao Zhou as a Postdoctoral researcher to investigate novel disease mechanisms underlying diabetes-associated cardiovascular complications and identify new therapeutic targets and reliable biomarkers